Journal
NEUROIMAGE
Volume 70, Issue -, Pages 33-36Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2012.12.044
Keywords
Alzheimer's; MRI; Longitudinal; Imaging; Database
Funding
- UK Alzheimer's Society
- GlaxoSmithKline
- Medical Research Council
- EPSRC [EP/H046410/1]
- Comprehensive Biomedical Research Centre (CBRC) Strategic Investment Award [168]
- Medical Research Council [MR/J014257/1]
- National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia based at University College London Hospitals (UCLH), University College London (UCL)
- Wellcome Trust [091593/Z/10/Z]
- EPSRC [EP/H046410/1] Funding Source: UKRI
- MRC [MR/J014257/1] Funding Source: UKRI
- Alzheimer's Society [166] Funding Source: researchfish
- Engineering and Physical Sciences Research Council [EP/H046410/1] Funding Source: researchfish
- Medical Research Council [MR/J014257/1] Funding Source: researchfish
Ask authors/readers for more resources
The Minimal Interval Resonance Imaging in Alzheimer's Disease (MIRIAD) dataset is a series of longitudinal volumetric T1 MRI scans of 46 mild-moderate Alzheimer's subjects and 23 controls. It consists of 708 scans conducted by the same radiographer with the same scanner and sequences at intervals of 2, 6, 14, 26, 38 and 52 weeks, 18 and 24 months from baseline, with accompanying information on gender, age and Mini Mental State Examination (MMSE) scores. Details of the cohort and imaging results have been described in peer-reviewed publications, and the data are here made publicly available as a common resource for researchers to develop, validate and compare techniques, particularly for measurement of longitudinal volume change in serially acquired MR. (c) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available